Gilder Gagnon Howe & CO LLC Unity Biotechnology, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$7.59 - $10.21 $141,158 - $189,885	-18,598 Closed	0 $0
Q1 2019 May 17, 2019	SELL	$7.65 - $16.66 $10,396 - $22,640	-1,359 Reduced 6.81%	18,598 $151,000
Q4 2018 Feb 14, 2019	SELL	$10.76 - $17.25 $462 - $741	-43 Reduced 0.22%	19,957 $325,000
Q2 2018 Jul 31, 2018	BUY	$12.76 - $16.94 $255,200 - $338,800	20,000 New	20,000 $301,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.